Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
These survival rates include people who die from causes other than cancer. The 5-year survival rate for people with stage IA NSCLC is about 49%. For people with stage IB NSCLC, the 5-year survival rate is about 45%. For stage IIA cancer, the 5-year survival rate is about 30%.